Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation
Chunqi Liu(Sichuan University), Yinglan Zhao(Sichuan University), Zong‐Guang Zhou(Sichuan University), Qingxiang Sun(University of Electronic Science and Technology of China), Yiyun Lin(The University of Texas MD Anderson Cancer Center), Hui Jie(Sichuan University), Xiaobo Cen(Sichuan University), Qianyi Deng(Sichuan University), Yong Peng(Sichuan University), Pengchi Deng(Sichuan University), Huijuan Wang(Society of Critical Care Medicine), Liang Wang(Ministry of Ecology and Environment), Jing Zhang(Central Hospital of Zibo), Lei Tao(Sichuan University), Yuping Tan(Sichuan University), Xiaocong Liu(Sichuan University), Yuzhou Xiao(Sichuan University), Huaqin Zhang(Sichuan University), Hu Zhang(Sichuan University)
Cited by 79
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
Targeting cellular metabolism to improve cancer therapeutics
|Cell Death and Disease|2013|1k
Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease
|Nature Genetics|2011|786
Tumor biomarkers for diagnosis, prognosis and targeted therapy
|Signal Transduction and Targeted Therapy|2024|600